ZHANG Feng graduated from Medical School of Nanjing University in 2002 with the master’s degree in surgery of clinical medicine (7-year program) and from Medical School of Nanjing University in 2009 with a doctorate in surgery; once paid academic visits in New York-Presbyterian Hospital of Cornell University, USA and the two major cancer centers in the USA, i.e. the MD Anderson Cancer Center and New York Memorial Sloan-Kettering Cancer Center as joint PhD student and visiting scholar respectively in 2008 and 2015; acted as resident physician, attending physician and responsible physician of Sir Run Run Shaw Hospital Zhejiang University School of Medicine and Women’s Hospital School of Medicine Zhejiang University from 2002 to 2006 and from 2010 to 2016 respectively; served as head of the Department of Breast Surgery of Women’s Hospital School of Medicine Zhejiang University, Ninghai Branch as expert of the Department of Health to the countryside from 2013 to 2014; was rated as the “Qianjiang Talent” of Zhejiang Province and “High-level Overseas Returnee” of Zhejiang Province in 2011.

Doctor of surgery jointly trained by Nanjing University, China and Cornell University, USA; youth member Clinical Nutritionist Committee of Surgeons Branch of Chinese Medical Doctor Association and member of Breast Health Care Professional Committee of Maternal and Child Health Care of China Association; visiting scholar to the two major cancer centers in the USA, i.e. the MD Anderson Cancer Center and New York Memorial Sloan-Kettering Cancer Center, visiting scholar sponsored by Department of Health of Zhejiang Province to German projects, expert under the program of “talents and resources to lower units” of Department of Health of Zhejiang Province, “Qianjiang Talent” of Zhejiang Province and “High-level Overseas Returnee” of Zhejiang Province; boasting over 10 years of extensive experience in clinical practice; published of over 10 high-level SCI papers; writer of the monograph on genetics and prevention of breast cancer published by American Springer Publishing Company; reviewer of SCI journals under American SPG Group and Greek Spandidos Publications; editorial board member of American Oncology Communications; the discoverer of the world’s first breast fibroblast reticular cell malignant tumor.

Focus on the prevention against and early diagnosis and treatment of breast cancer and in-depth study on the prevention against and high risk factors of breast malignant tumors; excel at standardized and individualized treatment of benign and malignant breast tumors, refined operation of modified radical mastectomy, breast protection radical correction and sentinel lymph node biopsy and other breast surgeries.